In GC cells, SCD1 has the capability to promote cell proliferation and migration, while also up-regulating the expression of anti-ferroptosis markers xCT and GPX4, which are also closely tied to the Wnt/β-catenin signaling pathway (Wang et al., 2020). Here, GPX4 is linked to gastric cancer.